Axon Enterprise, Inc.
$39.59B- Market cap
- $38.90B
- Debt
- +$1.89B
- Cash
- −$1.20B
Capital structure 95% equity / 5% debt · EV / Revenue 14.24x · EV proxy / EBITDA proxy 1877.67x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: AXON stock price at premium vs AMGN $478.85 current versus $40.59 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AMGN's multiple
Implied fair value · at AXON's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Multiple premium
Higher P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 95% equity / 5% debt · EV / Revenue 14.24x · EV proxy / EBITDA proxy 1877.67x
Capital structure 79% equity / 21% debt · EV / Revenue 6.86x · EV proxy / EBITDA proxy 17.71x
AMGN carries the larger enterprise value at $252.25B against $39.59B; AMGN trades on the lower EV / Revenue multiple (6.86x vs 14.24x); AMGN on the lower EV / EBITDA (17.71x vs 1877.67x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Axon Enterprise, Inc. · implied price per share
Bear
$23.07
Base
$28.02
Bull
$34.69
Amgen Inc. · implied price per share
Bear
$121.60
Base
$161.79
Bull
$216.01
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TYLER TECHNOLOGIES INC
AXON vs TYL
TELEDYNE TECHNOLOGIES INC
AXON vs TDY
LOCKHEED MARTIN CORP
AXON vs LMT
GENERAL DYNAMICS CORP
AXON vs GD
HUNTINGTON INGALLS INDUSTRIES, INC.
AXON vs HII
Howmet Aerospace Inc.
AXON vs HWM
REGENERON PHARMACEUTICALS, INC.
AXON vs REGN
BIOGEN INC.
AXON vs BIIB
VERTEX PHARMACEUTICALS INC / MA
AXON vs VRTX
Gilead Sciences, Inc.
AXON vs GILD
Moderna, Inc.
AXON vs MRNA
Eli Lilly and Company
AXON vs LLY
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.